KR20230164602A - 다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도 - Google Patents

다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도 Download PDF

Info

Publication number
KR20230164602A
KR20230164602A KR1020230067103A KR20230067103A KR20230164602A KR 20230164602 A KR20230164602 A KR 20230164602A KR 1020230067103 A KR1020230067103 A KR 1020230067103A KR 20230067103 A KR20230067103 A KR 20230067103A KR 20230164602 A KR20230164602 A KR 20230164602A
Authority
KR
South Korea
Prior art keywords
methyl
dihydropyrido
piperidin
pyrazine
chloro
Prior art date
Application number
KR1020230067103A
Other languages
English (en)
Korean (ko)
Inventor
윤수영
장창영
김병규
김윤영
김형진
정세환
곽영신
최민호
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Publication of KR20230164602A publication Critical patent/KR20230164602A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020230067103A 2022-05-25 2023-05-24 다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도 KR20230164602A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020220064386 2022-05-25
KR20220064386 2022-05-25

Publications (1)

Publication Number Publication Date
KR20230164602A true KR20230164602A (ko) 2023-12-04

Family

ID=88919738

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020230067103A KR20230164602A (ko) 2022-05-25 2023-05-24 다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도

Country Status (2)

Country Link
KR (1) KR20230164602A (fr)
WO (1) WO2023229380A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101595100B (zh) * 2007-01-16 2014-06-11 普渡制药公司 作为orl-1配体的杂环取代的哌啶
WO2011054433A1 (fr) * 2009-11-07 2011-05-12 Merck Patent Gmbh Hétéroarylaminoquinolines utilisées en tant qu'inhibiteurs de la kinase du récepteur tgf-bêta
AR119821A1 (es) * 2019-08-28 2022-01-12 Bristol Myers Squibb Co Compuestos de piridopirimidinonilo sustituidos útiles como activadores de células t
TW202200562A (zh) * 2020-04-29 2022-01-01 中國商北京泰德製藥股份有限公司 喹喔啉二酮衍生物作為kras g12c突變蛋白的不可逆抑制劑
US11767320B2 (en) * 2020-10-02 2023-09-26 Incyte Corporation Bicyclic dione compounds as inhibitors of KRAS

Also Published As

Publication number Publication date
WO2023229380A1 (fr) 2023-11-30

Similar Documents

Publication Publication Date Title
AU2018204431B2 (en) Compounds useful as inhibitors of ATR kinase
JP6378785B2 (ja) Tank結合キナーゼインヒビター化合物
AU2015320675B2 (en) Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds
CA3048376A1 (fr) Compose inhibiteur de signal bmp
KR20230164602A (ko) 다이아실글리세롤 키나아제 저해제로서 헤테로사이클 화합물 및 이의 용도
EP4003992A1 (fr) Dérivés de 4-(imidazo[1,2-a]pyridin-3-yl)-pyrimidine